AEPCX
Price
$59.44
Change
+$0.30 (+0.51%)
Updated
Sep 5 closing price
Net Assets
132.86B
AFCSX
Price
$18.67
Change
+$0.09 (+0.48%)
Updated
Sep 4 closing price
Net Assets
150.91M
Interact to see
Advertisement

AEPCX vs AFCSX

Header iconAEPCX vs AFCSX Comparison
Open Charts AEPCX vs AFCSXBanner chart's image
American Funds EUPAC C
Price$59.44
Change+$0.30 (+0.51%)
VolumeN/A
Net Assets132.86B
American Century Focused Intl Gr I
Price$18.67
Change+$0.09 (+0.48%)
VolumeN/A
Net Assets150.91M
AEPCX vs AFCSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AEPCX vs. AFCSX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Hold and AFCSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. AFCSX (151M). AEPCX pays higher dividends than AFCSX: AEPCX (0.16) vs AFCSX (0.00). AEPCX was incepted earlier than AFCSX: AEPCX (24 years) vs AFCSX (9 years). AEPCX (1.57) is less costly to investors than AFCSX (0.89). AFCSX is a more actively managed with annual turnover of: 82.00 vs. AEPCX (35.00). AEPCX has a lower initial minimum investment than AFCSX: AEPCX (250) vs AFCSX (5000000). AEPCX annual gain was more profitable for investors over the last year : 7.59 vs. AFCSX (7.11). AFCSX return over 5 years is better than : 14.73 vs. AEPCX (7.78).
AEPCXAFCSXAEPCX / AFCSX
Total Expense Ratio1.570.89176%
Annual Report Gross Expense Ratio1.570.89176%
Fund Existence24 years9 years-
Gain YTD15.03812.946116%
Front LoadN/AN/A-
Min. Initial Investment25050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets133B151M88,079%
Annual Yield % from dividends0.160.00-
Returns for 1 year7.597.11107%
Returns for 3 years32.6534.8994%
Returns for 5 years7.7814.7353%
Returns for 10 years34.34N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PACB1.270.03
+2.42%
Pacific Biosciences of California
VVX56.681.23
+2.22%
V2X
GANX1.760.02
+1.15%
Gain Therapeutics
LINE40.590.13
+0.32%
Lineage Inc.
QVCGP6.980.02
+0.29%
QVC Group Inc.